For decades, Omron has been synonymous with reliability in industrial automation - from PLC controllers and safety systems to sensors and collaborative robots. Yet the Japanese group is equally renowned for its role in healthcare, particularly in personal health monitoring devices.
Table of content
This unusual dual focus gives Omron a rare position in the global market: shaping the foundations of Industry 4.0 on one hand, while safeguarding the wellbeing of millions of people on the other. Recent months have underlined the company’s intent to strengthen both pillars, with investment moves and strategic decisions pointing to long-term ambition.
Investors Put Their Money on Omron
In early July 2025, Japan Activation Capital (JAC) acquired around 4 percent of Omron in a deal worth more than ¥30 billion (roughly $210 million). The move is a strong vote of confidence from global investors, who clearly see significant growth potential in both Omron’s industrial and healthcare businesses.
For Omron, the arrival of a heavyweight financial backer could mean greater pressure to accelerate innovation, expand its footprint and pursue new markets. But it is also a signal that the company’s long-standing strategy - balancing automation with healthcare - is paying off.
Strategic Expansion in India
At the same time, Omron announced plans for its first manufacturing site in India. The new facility in Chennai will produce medical devices, notably blood pressure monitors and portable ECG machines.
India represents an immense opportunity: a market of over a billion people, with a fast-growing middle class and rising awareness of personal healthcare. By setting up production locally, Omron is not only bringing itself closer to this expanding consumer base but also securing a launchpad for wider expansion across South Asia.
Automation Still at the Core
While healthcare developments have grabbed headlines, Omron has not slowed down in its core industrial automation business. The company continues to push forward with PLCs, cobots and safety solutions, while investing heavily in artificial intelligence and the Internet of Things.
These technologies go beyond process control to enable predictive maintenance and real-time optimisation of production. Meanwhile, Omron’s autonomous mobile robots (AGVs and AMRs) are gaining traction in sectors from electronics to pharmaceuticals, helping manufacturers streamline internal logistics.
A Business Model Like No Other
What sets Omron apart from rivals such as Siemens, Schneider Electric and Fanuc is its dual-track model. By straddling both industry and healthcare, the group has built resilience against downturns. When industrial orders dip, healthcare revenues often cushion the impact.
It’s a model that may prove instructive for others: combining advanced industrial technologies with solutions that improve everyday life.
Why It Matters
In the world of industrial automation, Omron remains a critical supplier of control and safety systems. Its products are trusted wherever precision and reliability are paramount - from automotive plants to electronics production and pharmaceuticals.
At the same time, investments in India and the arrival of JAC underline that Omron is no longer simply a technology story, but a financial one too. Global markets are watching closely.
Availability of Omron Components
For manufacturers, access to reliable spare parts remains vital. In Europe, trusted partners such as Automation Trader continue to provide a steady supply of Omron sensors, PLCs and safety modules. This ensures that even the most complex production lines can operate without disruption.
Looking Ahead
Omron today stands at a crossroads - strengthening its industrial automation portfolio while expanding its presence in global healthcare. This unusual combination could make the company one of the defining players of the next decade, shaping both factories and households alike.
If anything characterises Omron, it is consistency: Japanese precision, global reach and an unyielding focus on innovation. In a world where industry and health are increasingly intertwined, that may prove to be its greatest advantage.
